BioTuesdays
Oct 15, 7:02 PM
$VBIO and closely held LarmorBio today announced that Velocity Bioworks, Valion's wholly owned biologics contract development and manufacturing organization (CDMO) subsidiary, has successfully completed an initial feasibility evaluation of LarmorBio's BioScan-NMR platform less than six months after Valion secured exclusive rights to the NMR technology.
https://biotuesdays.com/2026/10/15/valions-next-gen-nmr-partnership-with-larmorbio-delivers-initial-feasibility-milestone/
0 replies